Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378989/
http://dx.doi.org/10.1007/s40278-020-80996-7
_version_ 1783562542521516032
collection PubMed
description
format Online
Article
Text
id pubmed-7378989
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73789892020-07-24 Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients Reactions Weekly Clinical Study Springer International Publishing 2020-07-25 2020 /pmc/articles/PMC7378989/ http://dx.doi.org/10.1007/s40278-020-80996-7 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
title Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
title_full Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
title_fullStr Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
title_full_unstemmed Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
title_short Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
title_sort risk of bradycardia with lopinavir/ritonavir in covid-19 patients
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378989/
http://dx.doi.org/10.1007/s40278-020-80996-7

Ejemplares similares